Immune therapy of chronic myelogenous leukemia

Leuk Res. 2005 May;29(5):583-6. doi: 10.1016/j.leukres.2004.11.005.
No abstract available

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fusion Proteins, bcr-abl / physiology
  • Humans
  • Immunotherapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*

Substances

  • Fusion Proteins, bcr-abl